Use of a mobile application for the control of anticoagulation with warfarin: a cluster randomized controlled clinical trial - Ijui/RS/Brazil

To evaluate the effectiveness of an anticoagulation protocol adapted in a mobile application (appG) for patients using warfarin. This was cluster randomized controlled clinical trial carried out basic health centers Ijui, RS, Brazil, between April and October 2017. The appG installed on cell phones all physicians belonging to intervention group. Primary outcomes were bleeding thrombosis, secondary changes dose warfarin, use new drugs, drug interactions, search services, remaining target international normalized ratio. Thirty-three 11 included this study. From these, 15 group which used appG, 18 control After 6 months, had fewer events (7% versus 50%, p-value=0.028) lower weekly warfarin (29.3 ± 9.7 mg 41.7 12.5 mg, p-value=0.030) when compared app reduced